drugset / Trial / NCT03347357

Pharmacokinetics of Tacrolimus in Children

NCT03347357 ↗

Phase 4 Completed 28 enrolled Shandong University
NaSingle-groupOpen-labelTreatment

Summary

the present study was conducted to assess the population pharmacokinetics of tacrolimus in children with nephrotic syndrome and to use these data to calculate an optimal dosing regimen of tacrolimus for use in these patients.

Timeline

Start
2012-01-01
Primary completion
2017-09-30
Completion
2017-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.05 mg/kg Oral

Indications